201 related articles for article (PubMed ID: 32260165)
41. PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance.
Zhang T; Liu Q; Zhu Y; Zhang S; Peng Q; Strickland AL; Zheng W; Zhou F
Cancer Manag Res; 2021; 13():9157-9165. PubMed ID: 34934360
[TBL] [Abstract][Full Text] [Related]
42. Immunohistochemical analysis of CD34 expression in salivary gland tumors.
Moghadam SA; Abadi AM; Mokhtari S
J Oral Maxillofac Pathol; 2015; 19(1):30-3. PubMed ID: 26097303
[TBL] [Abstract][Full Text] [Related]
43. Low-grade mucoepidermoid carcinoma of salivary glands: characteristic immunohistochemical profile and evidence of striated duct differentiation.
Foschini MP; Marucci G; Eusebi V
Virchows Arch; 2002 May; 440(5):536-42. PubMed ID: 12021929
[TBL] [Abstract][Full Text] [Related]
44. Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Clauditz TS; Reiff M; Gravert L; Gnoss A; Tsourlakis MC; Münscher A; Sauter G; Bokemeyer C; Knecht R; Wilczak W
Pathology; 2011 Aug; 43(5):459-64. PubMed ID: 21670724
[TBL] [Abstract][Full Text] [Related]
45. Pleomorphic adenoma and adenoid cystic carcinoma of salivary glands: E-cadherin immunoexpression and analysis of the CDH1 -160C/A polymorphism.
Cavalcante RB; Nonaka CF; Rabenhorst SH; da Costa Miguel MC; Pinto LP; de Souza LB
Arch Oral Biol; 2017 Jan; 73():48-54. PubMed ID: 27665273
[TBL] [Abstract][Full Text] [Related]
46. Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case-control study.
Sawabe M; Ito H; Takahara T; Oze I; Kawakita D; Yatabe Y; Hasegawa Y; Murakami S; Matsuo K
Cancer; 2018 Jan; 124(1):118-124. PubMed ID: 28881386
[TBL] [Abstract][Full Text] [Related]
47. Invasive myoepithelial carcinoma ex pleomorphic adenoma of the major salivary gland: two case reports.
Wakasaki T; Kubota M; Nakashima Y; Tomonobe E; Mihara T; Fukushima J
BMC Cancer; 2016 Oct; 16(1):827. PubMed ID: 27793123
[TBL] [Abstract][Full Text] [Related]
48. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
49. Morphometric analysis of CD34-positive vessels in salivary gland adenoid cystic and mucoepidermoid carcinomas.
Luukkaa H; Laitakari J; Vahlberg T; Klemi P; Stenbäck F; Grénman R
J Oral Pathol Med; 2009 Oct; 38(9):695-700. PubMed ID: 19674249
[TBL] [Abstract][Full Text] [Related]
50. Caveolin-1 overexpression in benign and malignant salivary gland tumors.
Jaafari-Ashkavandi Z; Ashraf MJ; Nazhvani AD; Azizi Z
Tumour Biol; 2016 Feb; 37(2):1863-9. PubMed ID: 26323261
[TBL] [Abstract][Full Text] [Related]
51. Common Malignant Salivary Gland Epithelial Tumors.
Seethala RR; Barnes EL
Surg Pathol Clin; 2011 Dec; 4(4):1177-215. PubMed ID: 26837790
[TBL] [Abstract][Full Text] [Related]
52. Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer.
Albrecht T; Brinkmann F; Albrecht M; Lonsdorf AS; Mehrabi A; Hoffmann K; Kulu Y; Charbel A; Vogel MN; Rupp C; Köhler B; Springfeld C; Schirmacher P; Roessler S; Goeppert B
Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33918309
[TBL] [Abstract][Full Text] [Related]
53. Lysozyme Expression Can be Useful to Distinguish Mammary Analog Secretory Carcinoma from Acinic Cell Carcinoma of Salivary Glands.
Mariano FV; Gómez CA; de Souza do Nascimento J; Dos Santos HT; Egal ES; Montalli VA; Vargas PA; de Almeida OP; Altemani A
Head Neck Pathol; 2016 Dec; 10(4):429-436. PubMed ID: 27177644
[TBL] [Abstract][Full Text] [Related]
54. Low p53 protein expression in salivary gland tumours compared with lung carcinomas.
Soini Y; Kamel D; Nuorva K; Lane DP; Vähäkangas K; Pääkkö P
Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):415-20. PubMed ID: 1333678
[TBL] [Abstract][Full Text] [Related]
55. Clinicopathological correlation of Cathepsin K expression in salivary gland carcinomas; relation to patients` outcome.
Elhendawy HA; Soliman S
Diagn Pathol; 2023 May; 18(1):66. PubMed ID: 37198626
[TBL] [Abstract][Full Text] [Related]
56. PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.
Ameratunga M; Asadi K; Lin X; Walkiewicz M; Murone C; Knight S; Mitchell P; Boutros P; John T
PLoS One; 2016; 11(4):e0153954. PubMed ID: 27104612
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical expression of androgen receptor in salivary gland cancers.
Sygut D; Bień S; Ziółkowska M; Sporny S
Pol J Pathol; 2008; 59(4):205-10. PubMed ID: 19391487
[TBL] [Abstract][Full Text] [Related]
58. Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm?
Alfieri S; Granata R; Bergamini C; Resteghini C; Bossi P; Licitra LF; Locati LD
Oral Oncol; 2017 Mar; 66():58-63. PubMed ID: 28249649
[TBL] [Abstract][Full Text] [Related]
59. Pathogenesis Analysis of Salivary Gland Tumors Through the Expression of Programmed Death-Ligand 1 (PD-L1).
Muna AI; Surya MEK; Margaretha M; Kosasih J; Syafriadi M
Indian J Otolaryngol Head Neck Surg; 2023 Dec; 75(4):3098-3102. PubMed ID: 37974781
[TBL] [Abstract][Full Text] [Related]
60. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
